More than two years after announcing plans to spin out its HIT division, Belgian graphics giant Agfa-Gevaert (EBR:AGFB) is reportedly putting the business on the auction block. In August 2017 the Brussels-based company began planning the establishment of the HIT division as a stand-alone business within Agfa-Gevaert. Yesterday the company began accepting bids in an auction […]
Health Technology
Medtronic launches GI Genius AI colonoscope
Medtronic (NYSE:MDT) said yesterday that it launched the GI Genius endoscopy module for detecting colorectal polyps in the treatment of colorectal cancer. The GI Genius is designed to use artificial intelligence to highlight pre-cancerous lesions with a visual marker, something Medtronic said can increase colorectal polyp detection rates. The Fridley, Minn.-based company said it is the […]
Fitbit inks cardiovascular monitoring deal with pharma alliance
The Bristol-Myers Squibb (NYSE:BMY)-Pfizer (NYSE:PFE) Alliance said today that it is working with Fitbit (NYSE:FIT) to improve earlier detection of atrial fibrillation in individuals with an increased risk of stroke. Fitbit and the alliance plan to work together on the development of educational content and guidance in support of people at increased risk for Afib. Fitbit is seeking […]
BioSig opens new office in Rochester, Minn.
BioSig Technologies (NSDQ:BSGM) said yesterday that it is opening a technology development office in Rochester, Minn., in collaboration with Mayo Clinic. Westport, Conn.-based BioSig said its new office will serve as an R&D and product development hub in support of the projects developed through its strategic collaboration with Mayo Clinic and Mayo Ventures. Mayo Clinic, having […]
How Medtronic could help change healthcare for the better
Medtronic officials want the world’s largest medtech company to do more than just make medical devices: They want to help manage chronic diseases. Here are thoughts from the VP helping to lead the shift. Medtronic executive Sheri Dodd had a cousin — one of only four — die from Type 2 diabetes complications at the age […]
After 20 years at Boston Scientific, here’s what this medtech R&D leader has learned
David Knapp, VP of corporate research at Boston Scientific, has spent 20 years developing devices that cut across divisions at the medtech giant. At DeviceTalks Minnesota 2019, he gave attendees an insider’s view of what he’s learned about device development and healthcare. Want to see these interviews live? Join us at DeviceTalks West – Dec. […]
Appeals court gives NeuroGrafix another shot at Brainlab in patent dispute
A federal appeals court has reinstated a long-running MRI patent lawsuit that NeuroGrafix brought against Brainlab. Santa Monica, Calif.-based NeuroGrafix claims that Brainlab (Munich, Germany) infringed on an MRI imaging patent. Two lower courts had dismissed the suit, but a three-judge U.S. Court of Appeals panel ruled yesterday that the latest ruling was “procedurally improper” […]
URGENT/11 cybersecurity vulnerabilities could affect medtech
This article has been updated with information from BD. Cybersecurity researchers have identified 11 vulnerabilities that could allow anyone to remotely take control of an imaging system, an infusion pump or an anesthesia machine, according to the FDA. More types of devices may be affected as well. The vulnerabilities, called URGENT/11, allow attacks to occur […]
Bay Labs rebrands as Caption Health
Bay Labs said today that it is renaming the company Caption Health and rebranding its flagship technology, EchoGPS, as Caption Guidance. The San Francisco-based company plans to incorporate Caption Guidance technology into compatible ultrasound devices and offer that product to the market as Caption AI. Caption AI is designed to allow for quick and accurate […]
How can medical device companies thrive in the future?
Medical device data is becoming more important than the hardware itself, so medtech companies need to forge a partnership with consumer technology companies to stay innovative, according to a new report from Deloitte. The Deloitte report — called “Winning the Future of Medtech” — came out yesterday in advance of next week’s AdvaMed MedTech Conference […]
DreaMed wins clearance, CE Mark for AI-powered insulin dosing software
DreaMed Diabetes today said it received FDA 510(k) clearance and CE Mark approval for its DreaMed Advisor Pro software. DreaMed Advisor Pro is an AI-based insulin dosing decision supply software designed for people with Type 1 diabetes using insulin pump therapy with continuous glucose sensors or blood glucose meters. The software previously received CE Mark approval […]